Monday, May 21, 2018

Latest Medical

adrienne107500 May 17, 2018 0 comments

Epidiolex Gives GW Pharmaceuticals Boost In Global Markets

GW Pharmaceuticals scored a significant victory in the United States with its cannabis-based epilepsy drug Epidiolex in mid-April. The company received approval from a U.S. Food and Drug Administration (FDA) panel for its use in treating two forms of drug-resistant epilepsy. The drug was granted “orphan drug” status in the
agency approval approve cannabinoid cannabis CBD cesamet company doctor dronabinol drug drug market efficacy Epidiolex epilepsy EU europe European FDA Federal GW GWPharma industry marijuana market medical medicine panel pharmaceutical physician process Product Development Regulatory review Sativex state synthetic thc U.S. Food and Drug Administration Uncategorized United States US
adrienne107500 May 8, 2018 0 comments

Ex-Im Europe: The Face of the Current Cannabis Market

In the United States, the idea of transporting cannabidiol (CBD), let alone medical cannabis across state lines is still verboten. As a result, a patchwork of very different state industries has sprung up across the map, with different regulatory mandates everywhere. While it is very clear that California will set
advocates Alcaliber Business Analysis canada cannabidiol cannabis canopy CBD cosnumer countries distributor drug east EU europe European european union export exportation exporting Federal Germany government hemp import importation importing industries industry insurance International legal legislation LP marijuana market medical medicine national policy Politics Portugal product recreational reform Regulatory Ritter Sport spain Spektrum state territory UK Uncategorized United Kingdom United States US West
adrienne107500 May 5, 2018 0 comments

Replacing Opiates with Cannabis is Finally Becoming a Reality: Where do we go from Here?

Opiate abuse is a far-reaching international public health issue, impacting tens of thousands of people every year in the United States alone. As the epidemic continues to spread, the medical community is faced with the immense task of researching and developing safer, non-addictive treatment alternatives for patients of chronic pain
administration analysis cannabinoids cannabis clinical trial controlled cost Department of Health and Human Services dosage dose dosing efficacy health legalization marijuana medical medication medicine opiate opioids pain pharmaceutical physician placebo practitioners product Product Development professional Quality regulation regulations Regulatory safe safety Soapbox Testing thc Uncategorized
adrienne107500 May 2, 2018 0 comments

Steep Hill Announces Major International Expansion

According to a press release, the Steep Hill team announced they are expanding internationally in a big way on Monday. Steep Hill, a well-known cannabis lab-testing and research company with roots in California, announced plans for licensing agreements in Mexico, Germany, Spain, France, Italy, Switzerland and the United Kingdom. Photo
analysis analytics Business California cannabis compliance consumer EU european union France Germany government industry International Italy lab laboratories Laboratories & Analytics laboratory labs law legal legalization legalize legislation license market medical medicine Mexico Quality RC - Cannabis Analysis regulation Regulatory spain Steep Hill Switzerland test Testing Uncategorized United Kingdom